Literature DB >> 3021278

An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice.

M Kavaliers, M Hirst.   

Abstract

The effects of intracerebroventricular administrations of an octadecaneuropeptide (ODN) derived from the polypeptide, diazepam binding inhibitor (DBI), on offensive and defensive aggression were examined in male mice. During the initial period after administration (1-5 min) ODN inhibited social and agonistic behavior. At 30 min after treatment, ODN increased, in a dose-dependent manner, the incidence of and intensity of offensive aggression in dominant resident mice. ODN also increased the number of bites required to obtain defeat in subordinate mice during aggressive interactions, as well as reducing subsequent defeat-induced analgesia. These changes in offensive and defensive aggressive behavior that were induced by ODN were reduced by the benzodiazepine receptor antagonist Ro 15-1788. These results suggest that ODN has significant modulatory effects on aggression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021278     DOI: 10.1016/0006-8993(86)90037-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Immunoreactive endozepine-like peptides in the brain and pituitary of the Atlantic hagfish, Myxine glutinosa.

Authors:  S Candiani; A Augello; D Oliveri; M Pestarino
Journal:  Histochem J       Date:  2000-07

2.  Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin.

Authors:  Y Li; Y Hao; C Owyang
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 3.  DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications.

Authors:  M L Barbaccia; A Berkovich; P Guarneri; E Slobodyansky
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

4.  Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain.

Authors:  I Lihrmann; J C Plaquevent; H Tostivint; R Raijmakers; M C Tonon; J M Conlon; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

5.  Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina.

Authors:  Minhua Wang; Xu Wang; Lian Zhao; Wenxin Ma; Ignacio R Rodriguez; Robert N Fariss; Wai T Wong
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

6.  Endogenous positive allosteric modulation of GABA(A) receptors by diazepam binding inhibitor.

Authors:  Catherine A Christian; Anne G Herbert; Rebecca L Holt; Kathy Peng; Kyla D Sherwood; Susanne Pangratz-Fuehrer; Uwe Rudolph; John R Huguenard
Journal:  Neuron       Date:  2013-05-30       Impact factor: 17.173

7.  Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides.

Authors:  Jean Luc Do Rego; Jae Young Seong; Delphine Burel; Jerôme Leprince; David Vaudry; Van Luu-The; Marie-Christine Tonon; Kazuyoshi Tsutsui; Georges Pelletier; Hubert Vaudry
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-24       Impact factor: 5.555

Review 8.  Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone.

Authors:  Pierrick Poisbeau; Anne Florence Keller; Maya Aouad; Nisrine Kamoun; Ghislaine Groyer; Michael Schumacher
Journal:  Front Cell Neurosci       Date:  2014-06-17       Impact factor: 5.505

9.  The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.

Authors:  Yosra Hamdi; Hadhemi Kaddour; David Vaudry; Seyma Bahdoudi; Salma Douiri; Jérôme Leprince; Helene Castel; Hubert Vaudry; Marie-Christine Tonon; Mohamed Amri; Olfa Masmoudi-Kouki
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

10.  The stimulatory effect of the octadecaneuropeptide ODN on astroglial antioxidant enzyme systems is mediated through a GPCR.

Authors:  Yosra Hamdi; Hadhemi Kaddour; David Vaudry; Salma Douiri; Seyma Bahdoudi; Jérôme Leprince; Hélène Castel; Hubert Vaudry; Mohamed Amri; Marie-Christine Tonon; Olfa Masmoudi-Kouki
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-21       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.